Clinic protocol for Covid-19 - Updated 29th June 2020
This document outlines my approach to mitigate the risks of cross infection of Covid-19.
There is a definite awareness of a heightened risk of cross infection via contact and droplet spread of this virus, and I have put certain procedures in place in my clinic to help prevent this.
I am using a number of separate control measures to minimise the potential for C-19 cross-infection & transmission:
1. Prior Screening by Questionnaire.
2. Physical distancing.
3. A minimal close-contact regime.
4. PPE – a barrier technique.
5. A strict cleanliness & asepsis protocol.
Under no circumstances will anyone displaying symptoms of C-19 be allowed into the clinic.
Screening: Patients will be asked to complete a pre-treatment screening questionnaire by telephone prior to treatment. If this is not done, I will be unable to see the patient.
Clinic: On entry to the clinic all patients will be asked to use hand sanitiser gel, and then to put on a Type IIR Facemask, which I will supply.
The clinic room is large, and I have divided it into 2 parts: a section for the patient and a section for the Osteopath. This will help minimise patients coming into contact with anything.
Timing: I am encouraging patients not to arrive before their allocated appointment time, as I do not want people congregating in the reception area.
Toilets: Other people in the building use the toilets. So if you do have to use the toilet I will supply you with the necessary sanitising kit.
Appointments: I have allowed 1 hour for all appointments. This allows 45 minutes face-to-face time, and 15 minutes to clean and ventilate the clinic room between patients.
Clinic Hygiene: The Clinic is regularly cleaned. All surfaces are cleaned between patients: chairs, door handles, card machine. Plinth, desk etc. and patients are encouraged to use sanitiser.
There are no longer towel covers on the plinth, and pillowcases have been replaced with hygienic, wipeable covers.
PPE: I will be wearing a Type IIR Facemask, disposable apron, a visor and nitrile gloves. I will ask you to wear a Type IIR Facemask.
If at any stage you are not comfortable with this level of PPE, please do tell me, and if necessary the treatment can be stopped.
Payment: Payment can be made by Card machine (sterilised prior to use) or by any other suitable method.
David Drysdale DO
COVID-19 SCREENING QUESTIONS
Please answer these questions the day before your appointment.
These questions are designed to help me assess your level of risk, and how likely you are to pass on the C-19 virus to other people.
You'll be asked these questions the day before your appointment and again when you arrive for your appointment, because your situation may have changed.
Please bear with me - this is aimed at keeping you, others and myself safe.
1. Do you or anyone in your household have symptoms of Covid-19 now or in the last 7 days?
The main symptoms of coronavirus (COVID-19) are:
* A high temperature – this means you feel hot to touch on your chest or back (you do not need to measure your temperature).
* A new, continuous cough – this means coughing a lot for more than an hour, or 3 or more coughing episodes in 24 hours (if you usually have a cough, it may be worse than usual).
* A loss or change to your sense of smell or taste – this means you've noticed you cannot smell or taste anything, or things smell or taste different to normal.
2. Have you or anyone in your household been in contact with someone with confirmed/suspected Covid-19 in the last 14 days?
3. Are you, or anyone with whom you are in regular contact, considered to be in a high-risk group if you contract the virus (clinically extremely vulnerable or clinically vulnerable – see groups below)?
4. Are you, or anyone in your household, at high risk of transmitting the virus by nature of your occupation e.g. a nurse, doctor, or care worker?
5. Do you have respiratory symptoms or conditions such as asthma or hay fever?
CLINICALLY EXTREMELY VULNERABLE
Clinically extremely vulnerable people have been advised to shield at home.
Disease severity, history or treatment levels will also affect who is in the group. This group may include the following people:
- Solid organ transplant recipients
- People with specific cancers:
- People with cancer who are undergoing active chemotherapy
- People with lung cancer who are undergoing radical radiotherapy
- People with cancers of the blood or bone marrow such as leukaemia, lymphoma or myeloma who are at any stage of treatment
- People having immunotherapy or other continuing antibody treatments for cancer
- People having other targeted cancer treatments which can affect the immune system, such as protein kinase inhibitors or PARP inhibitors
- People who have had a marrow or stem cell transplant in the last 6 months, or who are still taking immunosuppression drugs
- People with severe respiratory conditions including all cystic fibrosis, severe asthma and severe chronic obstructive pulmonary disease (COPD)
- People with rare diseases that significantly increase the risk of infections (such as SCID, homozygous sickle cell)
- People on immunosuppression therapies sufficient to significantly increase the risk of infection (inc high doses of steroids)
- Women who are pregnant with significant heart disease, congenital or acquired
Correct at 26/5/20
Clinically vulnerable people are those who are/have:
- Aged 70 or older (regardless of medical conditions)
- Under 70 with an underlying health condition
- Pregnant women
- A lung condition that is not severe (such as asthma, COPD, emphysema or bronchitis)
- Heart disease (such as heart failure)
- Chronic kidney disease
- Liver disease (such as hepatitis)
- A condition affecting the brain or nerves (such as Parkinson's disease, motor neurone disease, multiple sclerosis or cerebral palsy)
- A condition that means they have a high risk of getting infections
- Taking medicine that can affect the immune system (such as high doses of steroids)
- Very obese (a BMI of 40 or above)
Correct at 26/5/20